BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 11328217)

  • 1. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study.
    European Atosiban Study Group
    Acta Obstet Gynecol Scand; 2001 May; 80(5):413-22. PubMed ID: 11328217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group.
    Worldwide Atosiban versus Beta-agonists Study Group
    BJOG; 2001 Feb; 108(2):133-42. PubMed ID: 11236112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol.
    French/Australian Atosiban Investigators Group
    Eur J Obstet Gynecol Reprod Biol; 2001 Oct; 98(2):177-85. PubMed ID: 11574128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical experience of using oxytocin antagonist atosiban in the rescue therapy of preterm labour].
    Tan JP; Chen H; Du BJ; Liu YL; Wang YH; Zhang JP
    Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):81-4. PubMed ID: 18683742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue.
    Romero R; Sibai BM; Sanchez-Ramos L; Valenzuela GJ; Veille JC; Tabor B; Perry KG; Varner M; Goodwin TM; Lane R; Smith J; Shangold G; Creasy GW
    Am J Obstet Gynecol; 2000 May; 182(5):1173-83. PubMed ID: 10819855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group.
    Valenzuela GJ; Sanchez-Ramos L; Romero R; Silver HM; Koltun WD; Millar L; Hobbins J; Rayburn W; Shangold G; Wang J; Smith J; Creasy GW
    Am J Obstet Gynecol; 2000 May; 182(5):1184-90. PubMed ID: 10819856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of spontaneous preterm labor in Taiwanese women.
    Lin CH; Lin SY; Shyu MK; Chen SU; Lee CN
    J Formos Med Assoc; 2009 Jun; 108(6):493-501. PubMed ID: 19515630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxytocin receptor antagonists for inhibiting preterm labour.
    Flenady V; Reinebrant HE; Liley HG; Tambimuttu EG; Papatsonis DN
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD004452. PubMed ID: 24903678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study.
    Moutquin JM; Sherman D; Cohen H; Mohide PT; Hochner-Celnikier D; Fejgin M; Liston RM; Dansereau J; Mazor M; Shalev E; Boucher M; Glezerman M; Zimmer EZ; Rabinovici J
    Am J Obstet Gynecol; 2000 May; 182(5):1191-9. PubMed ID: 10819857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness and safety of atosiban vs. pulsatile administration of fenoterol in the treatment of preterm labour].
    Nonnenmacher A; Hopp H; Dudenhausen J
    Z Geburtshilfe Neonatol; 2009 Oct; 213(5):201-6. PubMed ID: 19856243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxytocin receptor antagonists for inhibiting preterm labour.
    Papatsonis D; Flenady V; Cole S; Liley H
    Cochrane Database Syst Rev; 2005 Jul; (3):CD004452. PubMed ID: 16034931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Atosiban Study Group.
    Goodwin TM; Valenzuela GJ; Silver H; Creasy G
    Obstet Gynecol; 1996 Sep; 88(3):331-6. PubMed ID: 8752234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atosiban versus usual care for the management of preterm labor.
    Husslein P; Cabero Roura L; Dudenhausen JW; Helmer H; Frydman R; Rizzo N; Schneider D
    J Perinat Med; 2007; 35(4):305-13. PubMed ID: 17614750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicentre, parallel group, randomised, single-blind study of the safety and efficacy of atosiban versus ritodrine in the treatment of acute preterm labour in Korean women.
    Shim JY; Park YW; Yoon BH; Cho YK; Yang JH; Lee Y; Kim A
    BJOG; 2006 Nov; 113(11):1228-34. PubMed ID: 16978233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of preterm labor with the oxytocin antagonist atosiban.
    Goodwin TM; Valenzuela G; Silver H; Hayashi R; Creasy GW; Lane R
    Am J Perinatol; 1996 Apr; 13(3):143-6. PubMed ID: 8688103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tocolytic therapy and clinical experience. Combination therapy.
    Ingemarsson I
    BJOG; 2005 Mar; 112 Suppl 1():89-93. PubMed ID: 15715603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atosiban.
    Shubert PJ
    Clin Obstet Gynecol; 1995 Dec; 38(4):722-4. PubMed ID: 8616970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human.
    Goodwin TM; Paul R; Silver H; Spellacy W; Parsons M; Chez R; Hayashi R; Valenzuela G; Creasy GW; Merriman R
    Am J Obstet Gynecol; 1994 Feb; 170(2):474-8. PubMed ID: 8116700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nifedipine compared with atosiban for treating preterm labor: a randomized controlled trial.
    Salim R; Garmi G; Nachum Z; Zafran N; Baram S; Shalev E
    Obstet Gynecol; 2012 Dec; 120(6):1323-31. PubMed ID: 23168756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical practice evaluation of combination of atosiban, ritodrine and ketoprofen for inhibiting preterm labor.
    Grignaffini A; Soncini E; Ronzoni E; Lo Cane F; Anfuso S; Nardelli GB
    Minerva Ginecol; 2007 Oct; 59(5):481-9. PubMed ID: 17912174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.